To better investigate GSK3β/N1-ICD interactions and to define whether pharmacologic GSK3β inhibition influenced them, we performed proximity ligation assay (PLA) in CLL cells cultured for 1.5 h with 5 μM SB216763 or DMSO (n = 3). The gene discussed is GSK3B; the disease is B-cell chronic lymphocytic leukemia.